Salary Range:CHF129,500.00 - CHF240,500.00 Job Description Summary#LI-Hybrid Location: Basel, Switzerland Internal title: Associate Director, Search & Evaluation Join us at the forefront of scientific innovation, where your insights can shape the future of Immunology at Novartis. In
Ironwood Pharmaceuticals is a leading global gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients. We are pioneers in the development of
Salary Range:CHF142,100.00 - CHF263,900.00 Job Description SummaryThe Director, Portfolio Analytics leads major portfolio analytics workstreams that inform enterprise, franchise, TA, and senior leadership decisions. The role shapes analytical approaches, interprets portfolio-level implications, advises stakeholders on value
Overview In this senior role, you will lead GCP audit and vendor management to uphold regulatory compliance and quality across clinical trials. You will partner with cross-functional teams to strengthen audit programs, CAPAs, and vendor performance,
Overview As Associate Director, Biostatistics, you will provide strategic and operational statistical leadership to guide clinical development at Ironwood. You will partner with cross-functional teams to shape development plans, create robust analyses, and support regulatory submissions. You’ll
Overview In this role you guide the Global Clinical Operations AI program, turning innovative concepts into scalable, compliant AI solutions that boost how teams operate. You’ll partner with Clinical Operations, Dev AI, Data, Digital and IT
Overview In this strategic global role, you will shape Abbott’s patient-centered engagement across regions, turning patient insights into business and policy decisions. You will build and evolve a worldwide patient engagement capability, collaborating with Medical Affairs,
Overview In this role, you will enable informed portfolio decisions for the Cardiovascular, Renal and Metabolic Development Unit by leading governance, analytics and executive reporting. You will partner with senior leaders to drive cross-functional alignment and
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)